Evidence map›Paper›PMID 35106582›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons.

Vin Tangpricha

Open access · hybridAbstract readEditorialComment
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Vin TangprichaDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-4021-5853
Emory University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Characteristics of COVID-19 in transgender peopleR01AG066956 · NIA · EMORY UNIVERSITY · PI GOODMAN, MICHAEL · 2021 to 2025
$3.5M
Mechanisms of TGF beta mediated suppression of metastasis in colon cancerR01CA140988 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WANG, JING · 2010 to 2014
$1.5M
Cohort study of mortality and morbidity in transgender personsR21HD076387 · NICHD · EMORY UNIVERSITY · PI GOODMAN, MICHAEL · 2013 to 2014
$451k
NCI NIH HHS R01 CA140988NIA NIH HHS R01 AG066956NICHD NIH HHS R21 HD076387NIH HHS UL1 RR025008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusTransgender PersonsFemaleGender IdentityHumansMaleTestosteroneTestosteronecardiovasculardiabetesestradioltestosteronetransgender

Identifiers

PMID35106582
PMCPMC9113784
OpenAlexW4210719246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.